Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

Lactabico Joins Biolabs Heidelberg, Establishes EU Presence

The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION

Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

Expert Speaker Lineup Revealed for Award Winning RBQM Event

Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.

Titian Software enters a 3-year agreement with leading life science company

Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.

EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat

Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment

DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation

DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.

The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change

The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.

Not every protein-protein interaction impacts cancer drug design

Researchers uncover a detailed action mechanism for protein MRG15, an important consideration for drugs targeting ASH1L which is overexpressed in many cancers. The findings from King Abdullah University of Science and Technology (KAUST), Saudi Arabia and the University of Michigan, U.S, could implicate the design of future cancer treatments.

African Pharmaceutical Market is expected to see a Double-Digit Growth by 2027 – Emerging Growth Opportunities in Africa

Rapidly growing African population and urbanization, an increasing number of chronic diseases, and growing healthcare spending's are some of the primary factors driving the growth of the African pharmaceutical market.

Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation

Thermo Fisher Scientific Introduces New Liquid Chromatography Detector

Huateng Pharma Announced To Attend CPhI Korea in August 2023

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB. Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Samsung Biologics Reports Second Quarter 2023 Financial Results

Recent Cash Injection Boosts VectorBuilder to Unicorn Status

VectorBuilder, a leading gene delivery technology company, announced with its latest cash injection that it reached a $1 billion valuation. VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. It is also a full-service CRO and CDMO supporting customers in their entire drug discovery pipeline, with over 4000 institutional customers worldwide. Gene delivery technologies enable precise manipulation of genetic information in cells and organisms. Besides being the workhorse of life sciences research for many decades, gene delivery technologies can correct genetic disorders, develop personalized medicine, and even enhance crop yields. This has sparked tremendous interest among scientists, clinicians, and industry leaders, making it a sought-after area of innovation and investment.

Biovian announces over €50 million investment in manufacturing facility in Turku, Finland

Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.

Pharma CEOs pen open letter calling suppliers to commit to sustainability targets

Signed by the CEOs of AstraZeneca, GSK, Merck, Novo Nordisk, Sanofi, Samsung Biologics, and the Chairman of Roche, the Health Systems Task Force is calling on suppliers to commit to joint, minimum climate and sustainability targets.

TransCure bioServices expands reach into APAC with Preclina Inc partnership

TransCure bioServices has expanded its reach in the APAC region by signing a strategic partnership with leading South Korean preclinical research company Preclina Inc.

CD Genomics Launches Advanced Whole Exome Sequencing Service, Empowering Genetic Research